Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

The post A Setback for MDMA-Assisted Psychotherapy appeared first on Reason.com. Autoblog chats to a hardcore Mustang fan and ...

The Multidisciplinary Association for Psychedelic Studies (MAPS) is pivoting its focus to state-level initiatives following ...

A Food and Drug Administration (FDA) advisory panel overwhelmingly rejected MDMA-assisted therapy for treating post-traumatic ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Amy Emerson is stepping down on the heels of the FDA last month rejecting Lykos Therapeutics’ MDMA-based therapy for ...

The CEO's departure comes after Lykos co-founder and longtime psychedelic medicines advocate Rick Doblin stood down from the ...

Psychedelics were high on the agenda for an official panel and public commenters, including the fallout from the FDA's MDMA ...

Lykos Therapeutics CEO Amy Emerson steps down following the FDA's rejection of the company's MDMA-based PTSD therapy.

I’ve had a lot of experience with MDMA, writes Rob Long. It helped me when my father died, and through several big life ...

WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using ...